Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale
Hofmann, Stefan G.
Carpenter, Joseph K.
Otto, Michael W.
Smits, Jasper A.J.
Pollack, Mark H.
MetadataShow full item record
CitationStefan G Hofmann, Joseph K Carpenter, Michael W Otto, David Rosenfield, Jasper AJ Smits, Mark H Pollack. 2015. "Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.." Contemp Clin Trials, Volume 43, pp. 223 - 230.
The use of D-cycloserine (DCS) as a cognitive enhancer to augment exposure-based cognitive-behavioral therapy (CBT) represents a promising new translational research direction with the goal to accelerate and optimize treatment response for anxiety disorders. Some studies suggest that DCS may not only augment extinction learning but could also facilitate fear memory reconsolidation. Therefore, the effect of DCS may depend on fear levels reported at the end of exposure sessions. This paper presents the rationale and design for a randomized controlled trial examining the relative efficacy of tailoring DCS administration based on exposure success (i.e. end fear levels) during a 5-session group CBT protocol for social anxiety disorder (n = 156). Specifically, tailored post-session DCS administration will be compared against untailored post-session DCS, untailored pre-session DCS, and pill placebo in terms of reduction in social anxiety symptoms and responder status. In addition, a subset of participants (n = 96) will undergo a fear extinction retention experiment prior to the clinical trial in which they will be randomly assigned to receive either DCS or placebo prior to extinguishing a conditioned fear. The results from this experimental paradigm will clarify the mechanism of the effects of DCS on exposure procedures. This study aims to serve as the first step toward developing an algorithm for the personalized use of DCS during CBT for social anxiety disorder, with the ultimate goal of optimizing treatment outcome for anxiety disorders.
Showing items related by title, author, creator and subject.
Enhancement of psychosocial treatment with D-cycloserine: models, moderators, and future directions Otto, Michael W.; Kredlow, M. Alexandra; Smits, Jasper A.J.; Hofmann, Stefan G.; Tolin, David F.; de Kleine, Rianne A.; van Minnen, Agnes; Evins, A. Eden; Pollack, Mark H. (2016-08-15)Advances in the understanding of the neurobiology of fear extinction have resulted in the development of d-cycloserine (DCS), a partial glutamatergic N-methyl-D-aspartate agonist, as an augmentation strategy for exposure ...
Des Roches, Carrie A.; Kiran, Swathi (Frontiers Research Foundation, 2017-07-28)The utilization of technology has allowed for several advances in aphasia rehabilitation for individuals with acquired brain injury. Thirty-one previous studies that provide technology-based language or language and cognitive ...
The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Meuret, Alicia E.; Chmielewski, Michael; Steele, Ashton M.; Rosenfield, David; Petersen, Sibylle; Smits, Jasper A.J.; Simon, Naomi M.; Otto, Michael W.; Marques, Luana; Pollack, Mark H.; Hofmann, Stefan G. (2016-06)OBJECTIVE: Perception of personal identity cannot be separated from the perception of the social context and one's social identity. Full involvement in group psychotherapy may require not only the awareness of personal ...